Emunamedica

Emunamedica was a private U.S. healthcare diagnostics and medical technology company focused on chronic wound care. The company developed a patented or patent-pending, clinically tested diagnostic system intended to predict whether a chronic wound, including diabetic foot ulcers, would heal under the current course of therapy. Its offering appears to have been positioned as a decision-support and prognostic tool for clinicians managing hard-to-heal wounds. Public business-directory and company-database sources indicate the company was founded in 2010, raised early venture funding, and later became inactive. Available evidence does not indicate a broad therapeutic drug pipeline; instead, the business centered on a wound-healing diagnostic platform.